New patent for drug Axsome AUVELITY – DrugPatentWatch
Annual Drug Patent Expiration for AUVELITY
Auvelity is a drug marketed by Axsome and included in one NDA. It is available from a single supplier. There are a hundred patents protecting this drug.
This drug has one hundred and forty patent family members in thirty countries.
The generic ingredient in AUVELITY is bupropion hydrochloride; dextromethorphan hydrobromide. One registered supplier for this compound. Additional details are available on bupropion hydrochloride; dextromethorphan hydrobromide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for the drug Axsome AUVELITY